Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-20

Clinical Trial Update: Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled Intake [NA]

View source ↗

Summary

The clinical trial evaluating tolerance and compliance of a high-calorie, high-protein oral nutritional supplement for malnutrition has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fresenius Kabi | Conditions: Malnutrition | NA | Status: COMPLETED